Abstract:Objective: To analyse the mechanism of invasion and metastasis of hepatocellular carcinoma by MST based on the MAPK-ERK signalling pathway. Methods: Human hepatoma cell lines were cultured in vitro and cells that were grown in logarithm were divided into a control group (8 cells, no treatment), a high expression group (8 cells, treatment with high expression of MST4 transfection), and a low expression group (8 cells, treatment with low expression of MST4 transfection). Real-time quantitative PCR was used to detect the expression of the inflammatory factors present in each group of hepatoma cells; MTT assay was used to detect the proliferation of cells in each group; Transwell assay was used to detect the invasion and migration ability of each group; Western blot was used to detect the expression of ERK, p-ERK protein; and ELISA was used to detect changes in the inflammatory factor levels in each group of rats. Results: The real-time quantitative PCR results showed that the transcription levels of IL-6, IL-1 beta, TNF-alpha, and CCL-2 in high expression group of MST4 cells were significantly higher than those in the control group and the low expression group, and the difference was statistically significant (P<0.01); the MTT assay showed that the absorbance of hepatocarcinoma cells in the high expression group was also found to be significantly higher than both the control group and the low expression group, with the difference being statistically significant (P<0.01). Transwell test results showed that the number of invasion and migration of hepatocarcinoma cells in the high expression group was also significantly higher than that of the control group and the low expression group, with the difference being statistically significant (P<0.01). The results of the Western blot showed that there was no significant difference in the expression of ERK protein between the three groups (P>0.05). Furthermore, it was found that the expression of p-ERK protein in the high expression group of MST4 was significantly higher than that of the control group and low expression group, and the difference was statistically significant (P<0.01). The secretion of IL-6, IL-1 beta, TNF-alpha, CCL-2 of liver cancer cells in high expression group was also significantly higher than that of the control group and the ERK inhibitor group (P<0.01), which indicated that ERK inhibitors can significantly inhibit the secretion of inflammatory factors by liver cancer cells. Conclusion: MST4 can promote tumour secretion of inflammatory factors and enhance the invasion and metastasis ability of liver cancer cells through a MAPK-ERK signalling pathway.

Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.

Infiltrating Regulatory T Cells Promote Invasiveness of Liver Cancer Cells Via Inducing Epithelial-Mesenchymal Transition

Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

Tumor-associated Macrophages Promote Human Hepatoma Huh-7 Cell Migration and Invasion Through the Gli2/IGF-II/ERK1/2 Axis by Secreting TGF-β1.

Targeting the Erk Pathway Reduces Liver Metastasis of Smad4-Inactivated Colorectal Cancer

Transactivation of the TIEG1 Confers Growth Inhibition of Transforming Growth Factor-Β-susceptible Hepatocellular Carcinoma Cells.

EGFR Mediates Epithelial‑mesenchymal Transition Through the Akt/GSK-3β/Snail Signaling Pathway to Promote Liver Cancer Proliferation and Migration.

EB2 Promotes Hepatocellular Carcinoma Proliferation and Metastasis Via MAPK/ERK Pathway by Modulating Microtubule Dynamics.

Study on invasion and metastasis of hepatocellular carcinoma by mst based on mapk-erk signaling pathway

Involvement Of Protein Kinase C Beta-Extracellular Signal-Regulating Kinase(1/2)/P38 Mitogen-Activated Protein Kinase-Heat Shock Protein 27 Activation In Hepatocellular Carcinoma Cell Motility And Invasion

Effects of CaMKⅡ/ERK signal pathway on TGFβ1-induced human hepatic stellate cell proliferation

TGF-β Signaling is Often Attenuated During Hepatotumorigenesis, but is Retained for the Malignancy of Hepatocellular Carcinoma Cells.

Downregulation of Epidermal Growth Factor Receptor in hepatocellular carcinoma facilitates Transforming Growth Factor-β-induced epithelial to amoeboid transition

ERK1/2 and JNK Signaling Synergistically Modulate Mitogenic Effect of Fibroblast Growth Factor 2 on Liver Cell

Effects of extracellular signal-regulated kinase 1 small interfering RNA on the proliferation of hepatoma cells

Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.

TGF-β Combined with EGFR Inhibitor Induce HCC Trans-Differentiation into Fibroblasts Via Epithelial-Mesenchymal Transition

TGF-β1 induced deficiency of linc00261 promotes epithelial–mesenchymal-transition and stemness of hepatocellular carcinoma via modulating SMAD3

TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll‐like‐receptor signalling

STAT3 Aggravates TGF-β1-induced Hepatic Epithelial-to-mesenchymal Transition and Migration.